Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et.

Trials and Research

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo.

Clinical Trials

Relapsed Grade 2/3 IDH-mutant glioma
Open

LUMOS2

Low & Anaplastic Grade Glioma Umbrella Study of Molecular Guided Therapies
Glioblastoma
In Follow-Up

MAGMA

The Multi-Arm GlioblastoMa Australasia (MAGMA) Trial
Glioblastoma
Completed

CABARET

A randomised phase II study of Carboplatin and Bevacizumab in Recurrent Glioblastoma Multiforme
Primary malignant brain tumour, brain metastases or advanced cancer
Completed

SEED

Self-reported evaluation of the adverse effects of dexamethasone
Glioma (G3) and Glioblastoma
Completed

ACED

Acetazolamide plus Dexamethasone versus dexamethasone alone in recurrent and/or progressive HGG
Glioma (G2 and G3)
Completed

LUMOS

Low & Intermediate Grade Glioma Umbrella Study of Molecular Guided Therapies
Glioma (G3)
Completed

CATNON

Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial
Glioblastoma
Completed

NUTMEG

A Randomised Phase II Study of NivolUmab and TeMozolomide vs Temozolomide alone in newly diagnosed Elderly patients with Glioblastoma
Medulloblastoma
Completed

PersoMed-I

Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I)
Glioblastoma
Completed

VERTU

A Randomised Phase II study of Veliparib, Radiotherapy and Temozolomide in patients with unmethylated O (6)-methylguanine-DNA methyltransferase (MGMT) Glioblastoma

Your donations to our Brain Tumour Research make a real difference